Zacks.com on MSN1d
BD Stock Rises on Biosero Deal for AI-Powered Robotic Cytometry Tech
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of ...
Pharmabiz1d
BD & Biosero collaborate to enable robotic integration with flow cytometers used in drug discovery and development
Franklin Lakes, New Jersey Saturday, January 25, 2025, 10:00 Hrs [IST] ...
BD And Biosero Partner To Integrate Robotics With Flow Cytometry
BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...
Contract Pharma2d
BD, Biosero Partner to Enable Robotic Integration with Flow Cytometers
BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...
Cure Today3d
Understanding the Concept of MRD for Patients With Cancer
Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it ...
bioAffinity secures Australian patent for lung cancer test
SAN ANTONIO - bioAffinity Technologies, Inc. (NASDAQ:BIAF; BIAFW), a company specializing in noninvasive early-stage lung ...
Cure Today9d
An Expert Breaks Down the Meaning of MRD Testing in Cancer Care
Dr. Christopher R. Flowers delved into the meaning of MRD, discussing different ways that it may be tested for in patients ...
BioAffinity patent application accepted by IP Australia for early stage LC test
Affinity Technologie announced that the Australian Patent Office or IP Australia, has accepted bioAffinity’s patent application for the ...
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...